Joseph E Payne, President & CEO, Director at Arcturus Therapeutics, holds 1.48M shares in Arcturus Therapeutics (Ticker: ARCT), holds 861.25K shares in GRI Bio (Ticker: GRI). Most recently, Joseph E Payne Bought ― shares of Arcturus Therapeutics on Nov 28, 2022 for an estimated value of 82.55K.
What is the percentage of profitable transactions made by Joseph E Payne?
The percentage of profitable transactions made by Joseph E Payne is 75%.
What is the average return per transaction made by Joseph E Payne?
The average return per transaction made by Joseph E Payne is 86.00%.
What stocks does Joseph E Payne hold?
Joseph E Payne holds: ARCT, GRI stocks.
What was Joseph E Payne’s latest transaction?
Joseph E Payne latest transaction was an Informative Buy of $82.55K.
What was Joseph E Payne's most profitable transaction?
Joseph E Payne’s most profitable transaction was an Informative Buy of ARCT stock on August 30, 2019. The return on the trade was 365.60%.
What is Joseph E Payne's role in Arcturus Therapeutics?
Joseph E Payne's role in Arcturus Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.